To evaluate effectiveness of Saruva thitha nirgundi thailam for the treatment of throat infection in children.

An Open Clinical Trial to evaluate the effectiveness of Saruva Thitha Nirgundi Thailam for the treatment of Virana Silethumam (Acute Pharyngo-Tonsillitis) in Children - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069475

Enrollment

Registered

2024-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified

Interventions

Intervention1: Saruva Thitha Nirgundi Thailam: 5 to 7 years- 3ml and 8 to 12 years - 5ml, twice a day for 14 days. oil bath weekly once Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Children with age group of 5 to 12 years of both sex. Enlarged tonsils with Brodsky scale Grade 2 and above. children also having at least three of the following symptoms: 1. Throat pain 2. Cough 3. Difficult to swallow 4. Fever 5. Halitosis

Exclusion criteria

Exclusion criteria: 1. Pneumonia 2. Oral candidiasis 3. Tuberculosis 4. Peritonsillar abscess

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug will be assessed based on reduction in quantitative assessment scales of clinical symptoms. Enlargement of tonsils will be assessed by Brodsky scale. Throat pain will be assessed by VAS score. Cough severity will be assessed by VAS score. Dysphagia will be assessed based on Bazaz dysphagia scale. Halitposis will be assessed based on organoleptic score.Timepoint: Baseline at the time of enrolment - 0th day. First follow up - 7th day. Second follow up- 14th day. End point 28th day.	—

Measure

Time frame

Efficacy of the trial drug will be assessed based on reduction in quantitative assessment scales of clinical symptoms. Enlargement of tonsils will be assessed by Brodsky scale. Throat pain will be assessed by VAS score. Cough severity will be assessed by VAS score. Dysphagia will be assessed based on Bazaz dysphagia scale. Halitposis will be assessed based on organoleptic score.Timepoint: Baseline at the time of enrolment - 0th day. First follow up - 7th day. Second follow up- 14th day. End point 28th day.

—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactK Suresh

National Institute of Siddha

drsureshherbal@gmail.com9962571137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026